Charity registration number 1110452 (England and Wales) Company registration number 05258486
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
LEGAL AND ADMINISTRATIVE INFORMATION
| Trustees | Prof S Myerson | |
|---|---|---|
| Dr N Keenan | ||
| Dr T Treibel | ||
| Dr P Garg | ||
| Dr M Hughes | ||
| Dr P Swoboda | ||
| Dr J Weir-McCall | ||
| Dr A Awaad | ||
| Dr J Khan | ||
| Dr A Singh | ||
| Secretary | Mr R Bazneh | |
| Country of incorporation | United Kingdom | 05258486 |
| (England and Wales) | ||
| Charity registration | England and Wales | 1110452 |
| Registered office | BSCMR | |
| 33 Turbine Way | ||
| Echotech | ||
| Business park | ||
| Swaffham | ||
| PE37 7XD | ||
| Independent examiner | Gravita Audit Oxford LLP | |
| First Floor, Park Central | ||
| 40-41 Park End Street | ||
| Oxford | ||
| OX1 1JD |
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
CONTENTS
| Page | |
|---|---|
| Trustees' report | 1 - 4 |
| Independent examiner's report | 5 |
| Statement of financial activities | 6 |
| Balance sheet | 7 |
| Notes to the financial statements | 8 - 12 |
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025
Members of the Board
The members of the Board during the year ended 31 December 2025 are set out on page 3.
The trustees are not entitled to and did not receive any remuneration during the year.
Under the terms of the statutory guarantee the trustees are deemed to be statutory members and as such have given an undertaking to contribute up to £1 each if called upon to do so.
Observers
To ensure that all areas relating to cardiovascular magnetic resonance are represented, the Board may appoint up to four observers who, at the absolute discretion of the Board, may attend meetings of the Board but they shall not have any right to vote at a meeting of the Board.
Account
The members of the Board submit the financial statements for the year ended 31 December 2025. The net income for the year is £38,955. The resources and their movement are as shown in the attached statement of financial activities.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charitable company's Memorandum & Articles of Association Incorporated 13 October 2004, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).
Objectives and activities
British Society of Cardiovascular Magnetic Resonance (BSCMR) is a charity set up and run by the trustees. BSCMR was established as a limited company by guarantee not having share capital on 13 October 2004. BSCMR was given charity status (number 1110452) in July 2005.
The common objects of the charity are:
• to promote clinical practice and research into cardiovascular magnetic resonance;
• to disseminate the useful results of such research, and to further the advancement of education in cardiovascular magnetic resonance for the public benefit.
The BSCMR has officially been an Affiliated Group of the British Cardiovascular Society (BCS) since April 2006, having worked closely with the BCS since its inception in October 2004.
- 1 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
Public Benefit
The Trustees confirm that they have complied with the duty in section 17(5) of the Charities Act 2011 to have due regard to the guidance published by the Charity Commission.
By promoting the clinical practice of, and research into cardiovascular magnetic resonance (CMR), the charity will help increase the availability of this important diagnostic tool within hospitals throughout the UK, improve its application and establish further indications for its use. Very likely, patient care will be significantly improved as a result.
By disseminating the results of useful research and educating healthcare professionals on CMR application and techniques, more healthcare professionals will become competent in the many applications of this extremely useful technique. Additionally healthcare professionals will have a better understanding of the advantages that CMR offers over other imaging modalities and for which patients CMR is the investigation of choice.
In turn, cardiovascular conditions that are otherwise difficult to assess and diagnose via other clinical imaging techniques alone, including congenital heart disease, pericardial disease, valvular heart disease, cardiomyopathies and cardiac transplantation, may be better understood, diagnosed and managed.
The resultant public benefit is therefore more accurate assessment, evaluation and diagnosis of these conditions, in turn allowing the most appropriate treatment to be given to relieve suffering.
Importantly CMR does not involve the use of ionising radiation, and the appropriate widespread use of this technique has the potential to reduce x-ray burden as well as unnecessary invasive investigations and interventions which all have recognised complications.
Public benefit
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charitable company should undertake.
Achievements and performance
Significant activities and achievements against objectives
The twentieth full year for the BSCMR was another successful and productive year for the society which has continued to grow and support its members in many ways, as well as providing important input into the national agenda in support of CMR. Considerable work once again took place on various BSCMR initiatives during the year, independently as a society and in collaboration with other groups and organisations. The BSCMR operates with a voluntary management committee/Board of trustees who met during the period on a roughly quarterly basis, mainly via teleconference.
By the end of the period, the society’s membership, comprising healthcare professionals with an interest in Cardiovascular Magnetic Resonance (CMR) stood at 756 members – this comprised of 621 online and 135 standing order members. The trustees are pleased with the level of membership which comprises a group with a keen interest in CMR.
Stepping down from Board in 2025 was the following:
Dr Daniel Sado Jane Francis
At the AGM it was agreed that the 21st Annual Meeting 2025 will be held on the 13th and 14th April 2026.
The 20th Annual Meeting held at the King’s College Strand campus, London on the 31st March and 1st April 2025 and was a complete success with full capacity of 200 delegates.
- 2 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
Financial review
Trustees have reviewed the reserves which, as shown on page 7, amounted to £93,591 at 31 December 2025. The surplus was carried forward to 1 January 2026.
The trustees were happy with our financial situation. We now have enough fund to operate as a charity for approximately three years if no further investments are achieved.
The continued goal for the Society, is to continue our current success of increased revenue through membership and our meetings. We will achieve this through delivering excellent education that will increase our sponsorship and attendance at our events.
The trustees will continue to closely monitor the financial situation to ensure that the charity is a going concern.
Reserves policy
It is the policy of the charitable company that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month’s expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charitable company’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.
Structure, governance and management
The charitable company is a company limited by guarantee.
The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:
Prof S Myerson Dr N Keenan Dr D Sado (Resigned 25 November 2025) Dr T Treibel Dr P Garg Dr M Hughes Dr P Swoboda Dr J Weir-McCall Ms J Francis (Resigned 31 October 2025) Dr A Awaad Dr J Khan Dr A Singh
Recruitment and appointment of trustees
None of the trustees has any beneficial interest in the company. All of the trustees are members of the company guarantee to contribute £1 in the event of a winding up.
Other matters
Investment policy
The trustees’ policy is to invest funds in easy access and low risk bank accounts.
Contributions by volunteers
We regret that it is not possible to calculate accurately and reflect in these accounts the immense contribution made to the charity by our volunteers, helpful members, advisors and of course our trustees, whose help contributes greatly to enhance the work of the charity. We are most grateful to them.
- 3 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
The trustees' report was approved by the Board of Trustees.
.............................. Dr T Treibel
Date: .............................................10th April 2026
- 4 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
I report to the trustees on my examination of the financial statements of British Society of Cardiovascular Magnetic Resonance (the charitable company) for the year ended 31 December 2025.
Responsibilities and basis of report
As the trustees of the charitable company (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.
Having satisfied myself that the financial statements of the charitable company are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charitable company’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
1 accounting records were not kept in respect of the charitable company as required by section 386 of the Companies Act 2006.
-
2 the financial statements do not accord with those records; or
-
3 the financial statements do not comply with the accounting requirements of section 396 of the Companies Act 2006 other than any requirement that the financial statements give a true and fair view, which is not a matter considered as part of an independent examination; or
-
4 the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Gary Pready FCA Gravita Audit Oxford LLP
First Floor, Park Central 40-41 Park End Street Oxford OX1 1JD
Dated: .........................1 May 2026
- 5 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2025
| Unrestricted | Unrestricted | ||
|---|---|---|---|
| funds | funds | ||
| 2025 | 2024 | ||
| Notes | £ | £ | |
| Income and endowments from: | |||
| Charitable activities | 3 | 93,533 | 65,315 |
| Other trading activities | 4 | - | 3,980 |
| Other income | 5 | 2,723 | 2,860 |
| Total income | 96,256 | 72,155 | |
| Expenditure on: | |||
| Charitable activities | 6 | 57,301 | 73,629 |
| Total expenditure | 57,301 | 73,629 | |
| Net income/(expenditure) and movement in funds | 38,955 | (1,474) | |
| Reconciliation of funds: | |||
| Fund balances at 1 January 2025 | 54,636 | 56,110 | |
| Fund balances at 31 December 2025 | 93,591 | 54,636 |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
- 6 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
BALANCE SHEET
AS AT 31 DECEMBER 2025
| Notes Current assets Cash at bank and in hand Creditors: amounts falling due within one year 11 Net current assets The funds of the charitable company Unrestricted funds |
2025 £ 98,891 5,300 |
£ 93,591 93,591 93,591 |
2024 £ 64,056 9,420 |
£ 54,636 |
|---|---|---|---|---|
| 54,636 | ||||
| 54,636 |
The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2025.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
10th April 2026 The financial statements were approved by the trustees on .........................
.............................. Dr T Treibel Trustee
Company registration number 05258486 (England and Wales)
- 7 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1 Accounting policies
Charity information
British Society of Cardiovascular Magnetic Resonance is a charitable company limited by guarantee incorporated in England and Wales. The registered office is BSCMR, 33 Turbine Way, Echotech, Business park, Swaffham, PE37 7XD.
1.1 Basis of preparation
The financial statements have been prepared in accordance with the charitable company's memorandum & articles of association incorporated 13 October 2004, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charitable company is a Public Benefit Entity as defined by FRS 102.
The charitable company has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.
The financial statements are prepared in sterling, which is the functional currency of the charitable company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2 Going concern
At the time of approving the financial statements, the trustees have a reasonable expectation that the charitable company has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3 Charitable funds
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
1.4 Income
Grants and voluntary income are recognised when the charitable company is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
1.5 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.
1.6 Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.
- 8 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
1 Accounting policies
(Continued)
Basic financial assets
Basic financial assets, which include cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Basic financial liabilities
Basic financial liabilities, which include creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the charitable company’s contractual obligations expire or are discharged or cancelled.
2 Critical accounting estimates and judgements
In the application of the charitable company’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3 Income from charitable activities
| Unrestricted | Unrestricted | |
|---|---|---|
| funds | funds | |
| 2025 | 2024 | |
| £ | £ | |
| Charitable activiites | ||
| Other income | 50,283 | 30,840 |
| Paypal registration and membership | 43,250 | 34,475 |
| 93,533 | 65,315 |
- 9 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
4 Income from other trading activities
| Unrestricted | Unrestricted | ||
|---|---|---|---|
| funds | funds | ||
| 2025 | 2024 | ||
| £ | £ | ||
| Trading income | - | 3,980 | |
| 5 | Other income | ||
| Unrestricted | Unrestricted | ||
| funds | funds | ||
| 2025 | 2024 | ||
| £ | £ | ||
| Other income | 2,723 | 2,860 | |
| 6 | Expenditure on charitable activities | ||
| Unrestricted | Unrestricted | ||
| funds | funds | ||
| 2025 | 2024 | ||
| £ | £ | ||
| Direct costs | |||
| Governance costs | 57,301 | 73,629 | |
| Analysis by fund | |||
| Unrestricted funds | 57,301 | 73,629 | |
| 7 | Net movement in funds | 2025 | 2024 |
| £ | £ | ||
| The net movement in funds is stated after charging/(crediting): | |||
| Fees payable for the independent examination of the charity's financial | |||
| statements | 3,300 | 3,000 |
8 Trustees
None of the trustees (or any persons connected with them) received any remuneration or benefits from the charitable company during the year (2024: nil).
- 10 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
9 Employees
The average monthly number of employees during the year was:
| 2025 | 2024 | |
|---|---|---|
| Number | Number | |
| Total | - | - |
There were no employees whose annual remuneration was more than £60,000.
10 Taxation
The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.
11 Creditors: amounts falling due within one year
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Accruals | 5,300 | 9,420 |
12 Control relationships
The company is limited by guarantee with the liability of the members limited to £1 each in the event of a winding up. Consequently, no trustee or group of trustees has overall control of the company.
13 Unrestricted funds
The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.
| At 1 January | Incoming | Resources | At 31 | |
|---|---|---|---|---|
| 2025 | resources | expended | December | |
| 2025 | ||||
| £ | £ | £ | £ | |
| General funds | 54,636 | 96,256 | (57,301) | 93,591 |
| Previous year: | At 1 January | Incoming | Resources | At 31 |
| 2024 | resources | expended | December | |
| 2024 | ||||
| £ | £ | £ | £ | |
| General funds | 56,110 | 72,155 | (73,629) | 54,636 |
- 11 -
BRITISH SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
| 14 | Analysis of net assets between funds | |
|---|---|---|
| Unrestricted | ||
| funds | ||
| 2025 | ||
| £ | ||
| Fund balances at 31 December 2025 are represented by: | ||
| Current assets/(liabilities) | 93,591 | |
| 93,591 | ||
| Unrestricted | ||
| funds | ||
| 2024 | ||
| £ | ||
| Fund balances at 31 December 2024 are represented by: | ||
| Current assets/(liabilities) | 54,636 | |
| 54,636 |
15 Related party transactions
During the year ended 31 December 2025, there were no related party transactions (2024: £nil) .
- 12 -